DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
20.80
+0.41 (2.01%)
At close: Apr 28, 2026, 4:00 PM EDT
20.77
-0.03 (-0.14%)
After-hours: Apr 28, 2026, 4:04 PM EDT
DBV Technologies Employees
DBV Technologies had 110 employees as of December 31, 2024. The number of employees increased by 5 or 4.76% compared to the previous year.
Employees
110
Change (1Y)
5
Growth (1Y)
4.76%
Revenue / Employee
$48,171
Profits / Employee
-$1,255,957
Market Cap
1.25B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 562 |
| Pharming Group | 407 |
| UroGen Pharma | 291 |
| uniQure | 221 |
| EyePoint | 214 |
| Zenas BioPharma | 167 |
| MoonLake Immunotherapeutics | 130 |
| Septerna | 130 |
DBVT News
- 26 days ago - DBV Technologies S.A.: Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 - Finanz Nachrichten
- 26 days ago - Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 - GlobeNewsWire
- 4 weeks ago - DBV Technologies S.A.: DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document - Finanz Nachrichten
- 4 weeks ago - DBV Technologies S.A.: DBV Technologies Reports Full Year 2025 Financial Results and Business Update - Finanz Nachrichten
- 4 weeks ago - DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document - GlobeNewsWire
- 4 weeks ago - DBV Technologies Reports Full Year 2025 Financial Results and Business Update - GlobeNewsWire
- 5 weeks ago - DBV Technologies S.A.: DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review - Finanz Nachrichten
- 5 weeks ago - DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review - GlobeNewsWire